FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.400 |
None |
1.000 |
2 |
1
|
2007 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Myasthenic Syndrome
|
disease |
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Talkativeness
|
disease |
|
Mental or Behavioral Dysfunction
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Familial hematuria
|
disease |
|
Disease or Syndrome
|
23
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Tumor-Associated Vasculature
|
disease |
|
Acquired Abnormality
|
84
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mesangioproliferative glomerulonephritis
|
disease |
|
Disease or Syndrome
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Behavioural and psychiatric symptoms of dementia
|
disease |
|
Mental or Behavioral Dysfunction
|
14
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Tubulointerstitial fibrosis
|
phenotype |
|
Disease or Syndrome
|
328
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Homocysteine measurement
|
phenotype |
|
Laboratory Procedure
|
23
|
33
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Kinesiophobia
|
disease |
|
Disease or Syndrome
|
14
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3
|
disease |
|
Finding
|
1
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Fibromuscular Dysplasia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
47
|
3
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.110 |
None |
1.000 |
1 |
|
2019 |
2019 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
586
|
125
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Myasthenic Syndromes, Congenital
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
57
|
40
|
0.050 |
None |
1.000 |
5 |
|
2003 |
2019 |
Meningomyelocele
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
89
|
27
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Myasthenic Syndromes, Congenital, Slow Channel
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
18
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2002 |
2002 |
Nail-Patella Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
38
|
18
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |